百亿A股原董事长，被查！

Core Viewpoint - The former Party Secretary and Chairman of China National Pharmaceutical Group, Gao Yuwen, is under investigation for serious violations of discipline and law, as announced by the Central Commission for Discipline Inspection and the National Supervisory Commission [2]. Group 1: Company Background - China National Pharmaceutical Group, a listed company controlled by General Technology Group, was established in 1983 as China Pharmaceutical Health Products Import and Export Corporation and became part of General Technology Group in 1999 [6]. - The company has developed an integrated industrial structure that includes pharmaceutical and medical device commerce, supported by pharmaceutical manufacturing, covering the entire industry chain from cultivation and processing to research, production, sales, logistics, import-export trade, academic promotion, and technical services [6]. Group 2: Financial Performance - In the first three quarters of the year, China National Pharmaceutical Group reported revenue of 25.894 billion yuan, a year-on-year decrease of 3.42%, and a net profit attributable to shareholders of 455 million yuan, down 4.64% year-on-year [6]. - As of December 26, the company's stock price was 10.47 yuan per share, reflecting a decline of 0.38%, with a market capitalization of 15.7 billion yuan [7].